These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 23357493)

  • 1. Chemoembolization and radioembolization for hepatocellular carcinoma.
    Salem R; Lewandowski RJ
    Clin Gastroenterol Hepatol; 2013 Jun; 11(6):604-11; quiz e43-4. PubMed ID: 23357493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New concepts in embolotherapy of HCC.
    Pesapane F; Nezami N; Patella F; Geschwind JF
    Med Oncol; 2017 Apr; 34(4):58. PubMed ID: 28299645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transarterial radioembolization versus chemoembolization for the treatment of hepatocellular carcinoma (TRACE): study protocol for a randomized controlled trial.
    Seinstra BA; Defreyne L; Lambert B; Lam MG; Verkooijen HM; van Erpecum KJ; van Hoek B; van Erkel AR; Coenraad MJ; Al Younis I; van Vlierberghe H; van den Bosch MA
    Trials; 2012 Aug; 13():144. PubMed ID: 22913492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on Embolization Therapies for Hepatocellular Carcinoma.
    Kishore S; Friedman T; Madoff DC
    Curr Oncol Rep; 2017 Jun; 19(6):40. PubMed ID: 28421483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoembolization and radioembolization.
    Sangro B
    Best Pract Res Clin Gastroenterol; 2014 Oct; 28(5):909-19. PubMed ID: 25260317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Transarterial ablation of hepatocellular carcinoma. Status and developments].
    Radeleff BA; Stampfl U; Sommer CM; Bellemann N; Hoffmann K; Ganten T; Ehehalt R; Kauczor HU
    Radiologe; 2012 Jan; 52(1):44-55. PubMed ID: 22249701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transarterial chemoembolization and radioembolization.
    Sangro B; Salem R
    Semin Liver Dis; 2014 Nov; 34(4):435-43. PubMed ID: 25369305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transarterial chemoembolization and yittrium-90 for liver cancer and other lesions.
    Minocha J; Salem R; Lewandowski RJ
    Clin Liver Dis; 2014 Nov; 18(4):877-90. PubMed ID: 25438288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current surgical treatment for hepatocellular carcinoma : critical appraisal of current guidelines].
    Clerc D; Halkic N; Demartines N; Melloul E
    Rev Med Suisse; 2017 Jun; 13(567):1258-1261. PubMed ID: 28643982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transvascular therapy of Hepatocellular Carcinoma (HCC), status and developments.
    Gnutzmann D; Kortes N; Sumkauskaite M; Schmitz A; Weiss KH; Radeleff B
    Minim Invasive Ther Allied Technol; 2018 Apr; 27(2):69-80. PubMed ID: 29381102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transarterial Therapies for Hepatocellular Carcinoma: a Comprehensive Review with Current Updates and Future Directions.
    Kumar Y; Sharma P; Bhatt N; Hooda K
    Asian Pac J Cancer Prev; 2016; 17(2):473-8. PubMed ID: 26925630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis: adjusted indirect comparison of drug-eluting bead transarterial chemoembolization versus
    Ludwig JM; Zhang D; Xing M; Kim HS
    Eur Radiol; 2017 May; 27(5):2031-2041. PubMed ID: 27562480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma.
    Salem R; Lewandowski RJ; Kulik L; Wang E; Riaz A; Ryu RK; Sato KT; Gupta R; Nikolaidis P; Miller FH; Yaghmai V; Ibrahim SM; Senthilnathan S; Baker T; Gates VL; Atassi B; Newman S; Memon K; Chen R; Vogelzang RL; Nemcek AA; Resnick SA; Chrisman HB; Carr J; Omary RA; Abecassis M; Benson AB; Mulcahy MF
    Gastroenterology; 2011 Feb; 140(2):497-507.e2. PubMed ID: 21044630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is Macroscopic Portal Vein Tumor Thrombosis of HCC Really an Exclusion for Liver Transplantation?
    Aydin C; Yilmaz S
    J Gastrointest Cancer; 2020 Dec; 51(4):1137-1140. PubMed ID: 32833219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Locoregional therapy for hepatocellular carcinoma.
    Guimaraes M; Uflacker R
    Clin Liver Dis; 2011 May; 15(2):395-421, vii-x. PubMed ID: 21689621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Locoregional radiological treatment for hepatocellular carcinoma; Which, when and how?
    Meza-Junco J; Montano-Loza AJ; Liu DM; Sawyer MB; Bain VG; Ma M; Owen R
    Cancer Treat Rev; 2012 Feb; 38(1):54-62. PubMed ID: 21726960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma.
    Abdel-Rahman OM; Elsayed Z
    Cochrane Database Syst Rev; 2016 Feb; 2():CD011313. PubMed ID: 26905230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current locoregional therapies and treatment strategies in hepatocellular carcinoma.
    Cardarelli-Leite L; Hadjivassiliou A; Klass D; Chung J; Ho SGF; Lim HJ; Kim PTW; Mujoomdar A; Liu DM
    Curr Oncol; 2020 Nov; 27(Suppl 3):S144-S151. PubMed ID: 33343208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 90Y radioembolization versus chemoembolization in the treatment of hepatocellular carcinoma: an analysis of comparative effectiveness.
    Xing M; Kokabi N; Camacho JC; Kooby DA; El-Rayes BF; Kim HS
    J Comp Eff Res; 2013 Jul; 2(4):435-44. PubMed ID: 24236684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of hepatocellular carcinoma.
    Blum HE
    Best Pract Res Clin Gastroenterol; 2005 Feb; 19(1):129-45. PubMed ID: 15757809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.